← Leaderboards
Michael Paul Busch
Blood Centers Of The Pacific
$27,300,254
Attributed
$27,300,254
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,475,254 · 10
CDC$4,825,000 · 2
By mechanism
N01$11,659,583 · 5
R01$7,797,014 · 3
U01$4,525,000 · 1
RC2$2,118,432 · 1
P50$937,725 · 1
R21$262,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Transfusion”
- Russell E Ware · Duke University$40,659,016
- Susan Fera Assmann · New England Research Institutes, Inc.$32,364,291
- Jeffrey Lee Carson · Univ Of Med/Dent Nj-R W Johnson Med Sch$30,236,292
- Gabriel Muyinda · Zambia National Blood Transfusion Srv$23,779,270
- Michael Rutledge Debaun · Vanderbilt University Medical Center$23,544,275
- Abhik Das · Research Triangle Institute$22,986,828
Research focus
TransfusionBlood TransfusionBlood DonorBloodSafetyFollow-UpProgramsClinical ResearchTransmission ProcessVascular Blood SupplyHuman SubjectReportingImmunologicsAffectResearch PersonnelLeukocytesRepositoryImmuneInfectionLeukocyte Activation /TransformationEpidemiologyPrevalenceBaseResearch Study
Grant awards (33)
Possible transfusion transmitted cerebral amyloid angiopathy: evaluation of transmission of Aβ using the RADAR repository$131,250
R21 · FY2025 · HL · contact PI
RFA-IP-24-046: Nationwide Cohort of Blood Donors to Estimate Burden of Respiratory Viruses and Immunologic Response$25,000
U01 · FY2025 · IP · contact PI
RFA-IP-24-046: Nationwide Cohort of Blood Donors to Estimate Burden of Respiratory Viruses and Immunologic Response$4,500,000
U01 · FY2024 · IP · contact PI
Possible transfusion transmitted cerebral amyloid angiopathy: evaluation of transmission of Aβ using the RADAR repository$131,250
R21 · FY2024 · HL · contact PI
REDS-IV-P - CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) - SARS-CoV-2/COVID-19 STUDIES$4,748,941
N01 · FY2020 · HL · contact PI
REDS-IV-P - CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS), PHASE 1.$3,754,594
N01 · FY2019 · HL · contact PI
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Lab$1,883,792
N01 · FY2011 · HL · contact PI
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Internat'l Site$1,094,568
N01 · FY2011 · HL · contact PI
Viral/Immune parameters of Dengue and WNV in donors: blood safety implications$1,066,706
RC2 · FY2010 · HL · contact PI
Mechanisms and clinical effects of microchimerism in transfused trauma patients$979,989
R01 · FY2010 · HL · contact PI
Mechanisms and clinical effects of microchimerism in transfused trauma patients$1,185,874
R01 · FY2009 · HL · contact PI
Viral/Immune parameters of Dengue and WNV in donors: blood safety implications$1,051,726
RC2 · FY2009 · HL · contact PI
Mechanisms and clinical effects of microchimerism in transfused trauma patients$1,235,637
R01 · FY2008 · HL · contact PI
Natural history of acute and chronic HCV in blood donors$77,278
R01 · FY2008 · HL · contact PI
Mechanisms and clinical effects of microchimerism in transfused trauma patients$1,246,772
R01 · FY2007 · HL · contact PI
Natural history of acute and chronic HCV in blood donors$347,954
R01 · FY2007 · HL · contact PI
Natural History and Pathogenesis of WNV in Viremic Dono*$100,000
R01 · FY2007 · CI · contact PI
Mechanisms and clinical effects of microchimerism in transfused trauma patients$1,028,163
R01 · FY2006 · HL · contact PI
Natural history of acute and chronic HCV in blood donors$340,630
R01 · FY2006 · HL · contact PI
Natural History and Pathogenesis of WNV in Viremic Dono*$200,000
R01 · FY2006 · CI · contact PI
REDS-II Central Laboratory-268047175-268047175$0
N01 · FY2006 · HB · contact PI
MICROCHIMERISM IN TRANSFUSION MEDICINE AND ORGAN TRANSPLANT REJECTION$394,025
P50 · FY2005 · HL
Natural history of acute and chronic HCV in blood donors$348,827
R01 · FY2005 · HL
Natural History and Pathogenesis of WNV in Viremic Dono*$0
R01 · FY2005 · CI
MICROCHIMERISM IN TRANSFUSION MEDICINE AND ORGAN TRANSPLANT REJECTION$382,549
P50 · FY2004 · HL
Natural history of acute and chronic HCV in blood donors$348,827
R01 · FY2004 · HL
Natural History and Pathogenesis of WNV in Viremic Dono*$0
R01 · FY2004 · CI
Natural history of acute and chronic HCV in blood donors$357,063
R01 · FY2003 · HL
MICROCHIMERISM IN TRANSFUSION MEDICINE AND ORGAN TRANSPLANT REJECTION$0
P50 · FY2002 · HL
MICROCHIMERISM IN TRANSFUSION MEDICINE AND ORGAN TRANSPLANT REJECTION$0
P50 · FY2001 · HL
CENTRAL LABORATORY FOR VIRAL ACTIVATION TRANSFUSION$177,688
N01 · FY2000 · HB
DONOR LEUKOCYTE ACTIVATION/PROLIFERATION POST-TRANSFUSION$161,151
P50 · FY2000 · HL
CENTRAL LABORATORY FOR VIRAL ACTIVATION TRANSFUSION$0
N01 · FY2000 · HB